Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 3/20 | 0.44 |
| ▸ | ALKBH5 | Q6P6C2 | 2/20 | 0.41 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.39 |
| ▸ | HIPK4 | Q8NE63 | 1/20 | 0.39 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.39 |
| ▸ | TYMS | P04818 | 1/20 | 0.38 |
| ▸ | AR | P10275 | 2/20 | 0.38 |
| ▸ | XPO1 | O14980 | 3/20 | 0.37 |
| ▸ | CFTR | P13569 | 2/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | RXRB | P28702 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24939862 | 0.85 | PIM3 (0.41) | NOTUMPIM3HIPK4SCN2ATYMS | |
| SCHEMBL24938793 | 0.83 | NPSR1 (0.46) | PIM3HIPK4SCN2ATYMSPTGS1 | |
| SCHEMBL24939813 | 0.81 | PIM3 (0.40) | NOTUMPIM3HIPK4SCN2ATYMS | |
| SCHEMBL24939847 | 0.81 | MYC (0.56) | NOTUMPIM3HIPK4SCN2ATYMS | |
| SCHEMBL6499776 | 0.80 | XPO1 (0.42) | ARXPO1 | |
| SCHEMBL24939776 | 0.80 | PTGS1 (0.51) | NOTUMPIM3HIPK4SCN2APTGS1 | |
| SCHEMBL24939827 | 0.78 | ALDH1A1 (0.47) | PIM3HIPK4SCN2ATYMSPTGS1 | |
| SCHEMBL6659492 | 0.76 | PTGS1 (0.55) | PIM3HIPK4SCN2ATYMSPTGS1 | |
| SCHEMBL10793190 | 0.76 | PTGS1 (0.51) | PTGS1PTGS2 | |
| SCHEMBL24939784 | 0.74 | PIM3 (0.43) | NOTUMALKBH5PIM3HIPK4SCN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230022129-A1 | RESIST MATERIAL AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230022129-A1 | RESIST MATERIAL AND PATTERNING PROCESS | GFER, LBR, PCNA | NOTUM 1742/4885ALKBH5 23/4885PIM3 1314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.